Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Testosterone affects stress hormone levels differently in adolescent and adult male rats.

Some medications can cause reversible hair loss by affecting hair growth cycles.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

GABA contributes to stress-related hair loss, and ginkgolide A may help treat it.

Plant extracts may help treat hormone-related hair loss.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Activating TRPV3 stops human hair growth.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.